Company Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis.
It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test.
The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008.
Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
| Country | United States |
| Founded | 2006 |
| IPO Date | Oct 30, 2013 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 815 |
| CEO | Marc Stapley |
Contact Details
Address: 6000 Shoreline Court, Suite 300 South San Francisco, California 94080 United States | |
| Phone | 650 243 6300 |
| Website | veracyte.com |
Stock Details
| Ticker Symbol | VCYT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001384101 |
| CUSIP Number | 92337F107 |
| ISIN Number | US92337F1075 |
| Employer ID | 20-5455398 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Marc A. Stapley | Chief Executive Officer and Director |
| Rebecca Chambers | Executive Vice President and Chief Financial Officer |
| Dr. Phillip G. Febbo M.D. | Chief Scientific and Medical Officer |
| Annie McGuire | Executive Vice President, General Counsel and Chief People Officer |
| Dr. John Leite Ph.D. | Chief Commercial Officer for CLIA Business |
| Jonathan Wygant | Vice President and Chief Accounting Officer |
| Steven French | Senior Vice President and Chief Information Officer |
| Karen Possemato | Senior Vice President of Corporate Marketing, Communications and Commercial Operations |
| Robert Brainin | Executive Vice President and Chief Business Officer |
| Corinne Danan | Senior Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 2, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 4, 2024 | 144 | Filing |
| Sep 4, 2024 | 8-K | Current Report |
| Aug 7, 2024 | 144 | Filing |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Jul 16, 2024 | 144 | Filing |
| Jul 16, 2024 | 144 | Filing |
| Jul 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jun 13, 2024 | 8-K | Current Report |